Response to Smith et al. Smith et al.' s criticisms of our commentary in EHP (102:354-356) fall into four general categories: arsenic methylation and detoxification; the recalculation of the slope factor for ingested arsenic; differences between U.S. and Taiwanese populations; and recent epidemiological analyses. As discussed below, we stand by our earlier conclusion that the dose-response relationship for arsenic carcinogenicity is likely to be nonlinear, and we feel that there is no basis for dismissing the methylation saturation hypothesis as one possible explanation for nonlinearity. We offer the following response to Smith et al.'s criticisms.
Arsenic methylation: We acknowledge that the issue of arsenic methylation and detoxification is complex; however, we believe that the methodological limitations we observed in the Hopenhayn-Rich et al. (1) article on arsenic methylation weaken their argument that human studies do not support a methylation threshold hypothesis for arsenic. Moreover, we call readers' attention to several recent studies that suggest that percent inorganic arsenic in urine is not as sensitive an indicator of the saturation of the methylation pathway as is the ratio of the percentage of urinary metabolites, MMA to DMA. Hughes et al. (2) demonstrated an increase in the relative percentage of MMA to DMA (per administered dose of arsenic) excreted in the urine of mice, with increase in dose. In single oral doses ranging from 0.5 to 5000 pg/kg, the ratio of MMA to DMA increased by approximately a factor of 10 from the lowest to the highest group. The relative percent of inorganic arsenic bound to tissue also increased with dose. The authors propose that inorganic arsenic binds to macromolecules and does not appear in urine until the binding becomes saturated. Therefore, inorganic arsenic is not as sensitive an indicator of saturation of the methylation pathway as is the concentration of methylated metabolites. Similarly, in an epidemiological study of humans exposed to elevated levels of arsenic in drinking water in Mexico, Del Razo et al. (3) report that the MMA:DMA ratio in urine was significantly increased in the study group by a factor of 2.4 times relative to that in the control population. In another epidemiological investigation of increased levels of arsenic in drinking water in northeast Taiwan, Froines (4) observed a statistical increase of 1.5 times in the ratio of percentages of urinary MMA: DMA in the exposed population relative to the controls.
In our commentary, we stated that Smith et al. (5) did not discuss the implications of detoxification in estimating potential risks from low-level exposures typical of the U.S. population. To Water ingestion rates also can significantly affect total arsenic exposure and the calculation of cancer slope factors. As discussed in our commentary, EPA has recently approved an RfD for arsenic based on Taiwanese data and a water consumption rate of 4.5 1/day for males and females (7) . While it is true that EPA had previously estimated Taiwanese water intake to be 3.5 1/day for males and 2 1/day for females (8) , the characterization by Smith et al. that the more recent estimate of 4.5 1/day comes from "a speculative EPA staff discussion with virtually no data to support it" is inappropriate. Abernathy and his colleagues considered discussions of water consumption rates with several individuals from a Taiwanese Blackfoot treatment cen- Taiwan are desirable and have not been performed, the recommendation of 4.5 I/day is, in our opinion, the most reasonable estimate of Taiwanese water ingestion rates available. Furthermore, adjustment of the drinking water consumption rate has more than a "small effect on risk estimates." By using a water consumption rate of 4.5 1/day, as opposed to 3.5 and 2 1/day for males and females, respectively, EPA's current CSF for skin cancer would be decreased from 1.75 to 0.89 kg-day/mg, a 51% reduction (10 Methionine and cysteine are two amino acids necessary for methylation that are components of the protein ingested in a healthy diet. We agree with Smith and coworkers that the Taiwanese study population, the Taiwanese average population, and the U.S. average population all exceed the recommended dietary allowance (RDA) for methionine plus cysteine of 0.9 g/day for a 70-kg adult male and 0.7 g/day for a 54-kg male. However, it is not known how excessive arsenic body burden (as experienced by the Taiwanese population) may quantitatively affect methyl donor group demand and, consequently, the efficiency of the body's methylation detoxification pathway. In fact, the impact of added demand for methyl groups from methionine and cysteine for xenobiotic detoxification is not considered in the RDA. Several animal studies provide strong evidence that amino acid deficiencies in the diet may adversely impact the body's ability to detoxify arsenic (11, 12) . It must be considered that the Taiwanese intake of methionine and cysteine, which is one-half that of the U.S. intake on a per killigram body weight basis (13) (14) (15) , could affect the detoxification ability under conditions of high demand for methyl groups due to excessive arsenic burden.
We acknowledge that Smith et al. discussed the role of humic acids as being possible confounders in the association between arsenic in drinking water and the incidence of internal cancers in an earlier paper (16) . However, the conclusion that "there is little, if any, evidence to support the claim that humic substances are the causes of disease in the blackfoot disease endemic area of Taiwan" ignores the fact that humic acid levels co-vary significantly with both arsenic in water [correlation coefficient of 0.42, p<0.05 (17) and the average annual incidence rate of bladder cancer. In addition, fluorescent substances humicc acids) isolated from the drinking water of the blackfoot endemic area in southeastern Taiwan have been found to be mutagenic (18) . Lu et al. (19) reported that humic acid-arsenic complexes administered to mice induced liver enzymes and caused liver peroxidation, whereas humic acid complexes with other metals did not. Thus, the potential impact of humic acids on cancer incidence should not be discounted.
Recent epidemiological analyses: We acknowledge the limitations of ecological epidemiological studies, where subjects are studied in groups and the exposure of each group is represented by a single figure. Both the Tseng et al. (20) It is also important to note that the Tseng analysis and others may have underestimated exposure (and thus overestimated potency), particularly in the low-dose groups, by using the median rather than the mean arsenic concentration per village to represent exposure. In villages with a distribution of well water arsenic concentrations that is skewed to the right (because there are a few wells with high arsenic levels), the median arsenic concentration will be considerably lower than the mean. In this case, if the fraction of people ingesting water at a defined arsenic level is directly proportional to the number of wells at a defined arsenic level, the mean arsenic concentration of population exposure would be a better estimate of exposure than the median. In villages with a more normal or uniform distribution of well water arsenic concentrations, the mean and median values would be more similar. Thus, use of the median rather than mean arsenic concentration to represent exposure could artificially increase the magnitude of effect observed. Specifically, if the distribution of arsenic in wells in the low-arsenic villages (most wells low with one or two high levels) is more skewed than in the higherarsenic villages (most wells high), use of the median to represent exposure would specifically increase the magnitude of the effect observed at low doses relative to high doses.
As a final note, we call attention to a more recent analysis by the Drinking Water Committee of EPA's Science Advisory Board (22) , prepared as part of a review of EPA's draft Drinking Water Criteria document on Inorganic Arsenic (23) . The Science Advisory Board agreed with EPA that there was an association between internal cancer and exposure to high levels of arsenic in drinking water. However, the board pointed to key uncertainties in the extrapolation of results from the Taiwanese population to U.S. populations which needed to be addressed before completing any quantitative risk assessment. Specifically, the board referred to data indicating that blood arsenic levels only become elevated when the levels of arsenic in water exceed 100 pg/l (24), suggesting nonlinearities in the pharmacokinetics of arsenic. They also referred to the importance of considering exposure to other sources of arsenic in the Taiwanese population, as indicated by higher blood arsenic levels in the general Taiwanese population as compared to Danish (25) 
